Results 21 to 30 of about 205,452 (211)

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. [PDF]

open access: yes, 2018
BackgroundThe value of induction chemotherapy (ICT) remains under investigation despite decades of research. New advancements in the field, specifically regarding the induction regimen of choice, have reignited interest in this approach for patients with
Cohen, EEW   +6 more
core   +1 more source

Head and neck squamous cell carcinoma survivorship care

open access: yesAustralian Journal of General Practice, 2019
Head and neck cancer is the seventh most commonly diagnosed cancer in Australia. More than 90% of these cancers are squamous cell carcinomas (SCCs). With advances in cancer therapies, survivorship care is becoming increasingly topical. In particular, general practitioners (GPs) will play an increasingly central part in the management of this unique ...
Joo, Koh   +3 more
openaire   +3 more sources

Hypoxia in Head and Neck Squamous Cell Carcinoma [PDF]

open access: yesISRN Otolaryngology, 2012
Hypoxia is a common feature in most of the solid tumors including head and neck squamous cell carcinoma (HNSCC). Hypoxia reflects the imbalance between oxygen consumption by the rapidly proliferating cancer cells and the insufficient oxygen delivery due to poor vascularization and blood supply.
John Zenghong Li   +4 more
openaire   +2 more sources

Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma

open access: yesTumor Biology, 2017
The aim of this study was to determine the methylation status of the genes encoding the vascular endothelial growth factor receptors and to evaluate the usefulness of VEGFR methylation as a prognostic indicator in head and neck squamous cell carcinoma ...
Yuki Misawa   +10 more
doaj   +1 more source

Circulating tumor cells in head and neck cancer: A review

open access: yesWorld Journal of Otorhinolaryngology-Head and Neck Surgery, 2016
Carcinoma of the head and neck represents 3.5% of all cancers, and the vast majority of these tumors are squamous cell carcinoma (HNSCC). With a stable overall survival rate of 50% among all stages, there is continued interested in developing measures ...
Kyle P. McMullen   +4 more
doaj   +1 more source

Cetuximab in squamous cell head and neck carcinomas

open access: yesAnnals of Oncology, 2007
The epidermal growth factor receptor (EGFR) antagonist, cetuximab, has recently been shown to enhance the effects of radiotherapy, and reports to date indicate that this effect occurs without any change in the pattern and severity of toxicity usually associated with head and neck radiation and/or chemotherapy (CT) administration.
GEBBIA, Vittorio   +5 more
openaire   +3 more sources

Oral squamous cell carcinoma of tongue: Histological risk assessment. A pilot study [PDF]

open access: yes, 2019
Background: More than 90% of malignant tumors diagnosed in the oral cavity are Oral Squamous Cell Carcinomas (OSCC) whose preferred location is the tongue.
Cebrián Carretero, José Luis   +4 more
core   +3 more sources

Tim-3-expressing macrophages are functionally suppressed and expanded in oral squamous cell carcinoma due to virus-induced Gal-9 expression

open access: yesTumor Biology, 2017
Oropharyngeal head and neck squamous cell carcinoma is a common malignant tumor in the oral cavity. High-risk human papillomavirus 16 infection is a major cause of oropharyngeal head and neck squamous cell carcinoma development.
Jianfeng Dong   +5 more
doaj   +1 more source

Correlation between T and N Stages of Head and Neck Squamous Cell Carcinoma

open access: yesJournal of College of Medical Sciences-Nepal, 2015
Background and Objective: Squamous cell carcinoma of the head and neck region is a common pathological entity. Advanced primary lesion (T) and neck node metastasis (N) both are bad prognostic features for the carcinoma.
Krishna Koirala   +2 more
doaj   +1 more source

Extracellular vesicles cargo from head and neck cancer cell lines disrupt dendritic cells function and match plasma microRNAs

open access: yesScientific Reports, 2021
Extracellular vesicles (EVs) are mediators of the immune system response. Encapsulated in EVs, microRNAs can be transferred between cancer and immune cells.
Elisangela de Paula Silva   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy